Mereo BioPharma Group PLC (MREO)

4.25 +0.26 (+6.52%) USD  |  NASDAQ  |  Jun 14, 16:00
4.235 -0.02 (-0.35%) After-Hours: 20:00
More

Mereo BioPharma Group Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
June 12, 2024 --
May 16, 2024 --
Date Value
May 09, 2022 --
April 11, 2022 --

Revenue Estimates for Current Quarter Range, Past 5 Years

--
Minimum
Apr 11 2022
--
Maximum
Apr 11 2022
--
Average
--
Median
Apr 11 2022

Revenue Estimates for Current Quarter Benchmarks

Biodexa Pharmaceuticals Plc --
NuCana PLC Upgrade
Adaptimmune Therapeutics PLC Upgrade
Autolus Therapeutics PLC Upgrade
TC BioPharm (Holdings) PLC Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade